Physician Wealth Advisors’s Cytokinetics CYTK Stock Holding History

Physician Wealth Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.17K	Sell	49 -4	-8%	-$287	﹤0.01%	1179
2026 Q1	$3.49K	Sell	53 -4	-7%	-$254	﹤0.01%	1121
2025 Q4	$3.62K	Buy	57 +26	+84%	+$1.62K	﹤0.01%	1080
2025 Q3	$1.7K	Buy	+31	New	+$1.28K	﹤0.01%	1302
2025 Q1	–	Sell	-12	Closed	-$565	–	1460
2024 Q4	$565	Buy	+12	New	+$623	﹤0.01%	1095

Other funds holding CYTK

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Physician Wealth Advisors's CYTK Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Cytokinetics (CYTK) stake by 7.5% in Q2 2026, selling an estimated $287 and leaving 49 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Physician Wealth Advisors first reported a position in CYTK in Q4 2024 and has held it in 5 quarters since. 44 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Physician Wealth Advisors held 49 shares of Cytokinetics worth $4.17K as of Q2 2026.
Physician Wealth Advisors sold 4 Cytokinetics shares in Q2 2026, an estimated $287.
Cytokinetics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1179 holding.
Physician Wealth Advisors first reported a position in Cytokinetics in Q4 2024 and has held it in 5 quarters since.
44 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.